YEREVAN, June 9. /ARKA/. Arpimed, an Armenian company, intends to invest AMD 400 million in pharmaceutical industry, Suren Karayan, Armenian economic development and investments minister, said Thursday at a regular Cabinet meeting.   

At this session, the government decided to exempt the company form paying duties for importing technical equipment and raw materials and also provided a VAT payment adjournment.

“The company is also planning to create 12 new jobs with the average salary of AMD 200,000,” Karayan said. 

The output is expected to amount to AMD 800 million, where products worth AMD 500 million will be sold in Armenia’s territory, AMD 200 million in the Eurasian Economic Union’s space and AMD 100 million in other countries.  

Arpimed pharmaceutical company was established in 2001. This is a new-generation company which uses advanced trends in pharmaceutical industry development. ($1 – AMD 482.57). -0—